Cabergoline Combined Hydroxychloroquine/Chloroquine to Treat Resistant Prolactinomas
Clinical trial NCT03400865 · UNKNOWN
Trial details
- NCT number
- NCT03400865
- Sponsor
- Zhebao Wu
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-25
- Primary completion
- 2020-12-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.